Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank of America Corp (BAC) vs Crispr Therapeutics AG (CRSP) Price & Performance

Bank of America CorpTrade
Crispr Therapeutics AGTrade

Price performance (Past 24H)

Key statistics

Bank of America Corp vs Crispr Therapeutics AG — how do they compare? Bank of America Corp trades at $63.93 (market cap $446.56B), while Crispr Therapeutics AG trades at $53.88 (market cap $5.17B). The key difference: Bank of America Corp is far larger — about 86.4× Crispr Therapeutics AG's market cap, and Bank of America Corp pays a 2% dividend while Crispr Therapeutics AG pays none. Which is the better fit depends on your goals.

BACCRSP
Market Cap
$446.56B$5.17B
Volume
55,637,172
Sector
FinancialsHealth
52-Week High
$64.00$76.78
52-Week Low
$46.72$44.34
Dividend Yield
2%
Enterprise Value
$3.59B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Bank of America Corp

Bank of America (BAC) trades at $64.00, up 1.31% today, with a bullish technical signal and consistent earnings beats in recent quarters. The stock shows strong fundamentals, including a P/E of 14.75 and net income margin of 28.21%, supported by revenue growth to $113.10 billion in 2025. Recent news highlights partnerships, hiring initiatives, and positive analyst coverage, with a consensus price target of $67.36.

Outlook remains positive with potential upside from capital returns and earnings growth, though risks include macroeconomic sensitivity and high RSI levels. Analyst consensus is strongly bullish with 64.82% buy ratings, indicating confidence in BAC's deposit franchise and operational strength amid evolving rate cycles.

Crispr Therapeutics AG

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Bank of America Corp

Bank of America Corporation operates as a financial holding company. The Company offers saving accounts, deposits, mortgage and construction loans, cash and wealth management, certificates of deposit, investment funds, credit and debit cards, insurance, mobile, and online banking services. Bank of America serves customers worldwide.

Read more on BAC

About Crispr Therapeutics AG

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Read more on CRSP